Ampicillin-Sulbactam for Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis

氨苄西林-舒巴坦治疗耐碳青霉烯类鲍曼不动杆菌脑膜炎

阅读:1

Abstract

Carbapenem-resistant Acinetobacter baumannii (CRAB) is a rare but potentially fatal cause of post-neurosurgical meningitis, primarily due to its broad antimicrobial resistance and limited therapeutic options. We report the case of an eight-year-old girl who developed CRAB meningitis following ventriculoperitoneal shunt surgery. The organism was identified using standard biochemical methods and confirmed with an automated system (VITEK 2 Compact, BioMérieux SA, Marcy-l'Étoile, France). Antibiotic susceptibility testing revealed resistance to carbapenems and susceptibility only to colistin. The patient was treated successfully with a combination of high-dose intravenous ampicillin-sulbactam and intraventricular colistin following shunt exteriorization. Clinical improvement was observed within one week, and cerebrospinal fluid cultures subsequently became sterile. This case highlights the potential role of ampicillin-sulbactam, in combination with colistin, as an effective therapeutic option in managing post-neurosurgical CRAB meningitis, especially in pediatric patients where alternative agents are limited.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。